291 related articles for article (PubMed ID: 16522749)
1. Ezrin--a useful factor in the prognosis of nephrotic syndrome in children: an immunohistochemical approach.
Ostalska-Nowicka D; Zachwieja J; Nowicki M; Kaczmarek E; Siwinska A; Witt M
J Clin Pathol; 2006 Sep; 59(9):916-20. PubMed ID: 16522749
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of galectin-1 in renal biopsy specimens of children and its possible role in proteinuric glomerulopathies.
Ostalska-Nowicka D; Zachwieja J; Nowicki M; Kaczmarek E; Siwińska A; Witt M
Histopathology; 2007 Oct; 51(4):468-76. PubMed ID: 17880528
[TBL] [Abstract][Full Text] [Related]
3. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical analysis of podocytopathy with immature glomeruli and glomerulosclerosis in children with nephrotic syndrome].
Ostalska-Nowicka D; Zachwieja J; Nowicki M; Siwińska A; Woźniak A
Przegl Lek; 2006; 63 Suppl 3():97-100. PubMed ID: 16898501
[TBL] [Abstract][Full Text] [Related]
5. Reduced INF2 expression in nephrotic syndrome is possibly related to clinical severity of steroid resistance in children.
Tamura H; Nakazato H; Kuraoka S; Yoneda K; Takahashi W; Endo F
Nephrology (Carlton); 2016 Jun; 21(6):467-75. PubMed ID: 26383224
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of podocalyxin expression in glomerulopathies associated with nephrotic syndrome.
Kavoura E; Gakiopoulou H; Paraskevakou H; Marinaki S; Agrogiannis G; Stofas A; Boletis I; Patsouris E; Lazaris AC
Hum Pathol; 2011 Feb; 42(2):227-35. PubMed ID: 21106221
[TBL] [Abstract][Full Text] [Related]
7. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[TBL] [Abstract][Full Text] [Related]
8. Synaptopodin expression in idiopathic nephrotic syndrome of childhood.
Srivastava T; Garola RE; Whiting JM; Alon US
Kidney Int; 2001 Jan; 59(1):118-25. PubMed ID: 11135064
[TBL] [Abstract][Full Text] [Related]
9. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
[TBL] [Abstract][Full Text] [Related]
10. [Minimal change disease and focal segmental glomerulosclerosis].
Müller-Deile J; Schenk H; Schiffer M
Internist (Berl); 2019 May; 60(5):450-457. PubMed ID: 30887070
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor (VEGF-C1)-dependent inflammatory response of podocytes in nephrotic syndrome glomerulopathies in children: an immunohistochemical approach.
Ostalska-Nowicka D; Zachwieja J; Nowicki M; Kaczmarek E; Siwinska A; Witt M
Histopathology; 2005 Feb; 46(2):176-83. PubMed ID: 15693890
[TBL] [Abstract][Full Text] [Related]
12. Is mesangial hypercellularity with glomerular immaturity a variant of glomerulosclerosis?
Ostalska-Nowicka D; Zachwieja J; Nowicki M; Kaczmarek E; Witt M
Pediatr Nephrol; 2007 May; 22(5):674-83. PubMed ID: 17235549
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
[TBL] [Abstract][Full Text] [Related]
14. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
Srivastava T; Garola RE; Singh HK
Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
[TBL] [Abstract][Full Text] [Related]
15. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
Voznesenskaia TS; Sergeeva TV
Ter Arkh; 2002; 74(6):31-3. PubMed ID: 12136479
[TBL] [Abstract][Full Text] [Related]
16. Synaptopodin immunoexpression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis.
Wagrowska-Danilewicz M; Danilewicz M
Nefrologia; 2007; 27(6):710-5. PubMed ID: 18336100
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
Mishra OP; Kumar R; Narayan G; Srivastava P; Abhinay A; Prasad R; Singh A; Batra VV
Pediatr Nephrol; 2017 Aug; 32(8):1355-1361. PubMed ID: 28210837
[TBL] [Abstract][Full Text] [Related]
18. Do current recommendations for kidney biopsy in nephrotic syndrome need modifications?
Gulati S; Sharma AP; Sharma RK; Gupta A; Gupta RK
Pediatr Nephrol; 2002 Jun; 17(6):404-8. PubMed ID: 12107803
[TBL] [Abstract][Full Text] [Related]
19. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[TBL] [Abstract][Full Text] [Related]
20. Glomerular malondialdehyde levels in patients with focal and segmental glomerulosclerosis and minimal change disease.
Nezhad ST; Momeni B; Basiratnia M
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):886-91. PubMed ID: 20814126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
